{"schema_version":"secwatch.filing_event.v1","accession":"0001110803-23-000028","form_type":"8-K","ticker":"ILMN","cik":"0001110803","company_name":"ILLUMINA, INC.","filed_at":"2023-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.969894+00:00","generated_at":"2026-06-16T15:30:15.652750+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Illumina Q1 revenue down 11% YoY to $1.09B; GAAP EPS $0.02 vs $0.55; reiterates FY23 guidance","bullets":["Revenue $1.087B, down 11% YoY (down 9% constant currency); GAAP diluted EPS $0.02 vs $0.55.","Non-GAAP diluted EPS $0.08 vs $1.07; non-GAAP operating margin 1.9% vs 17.3%.","Reiterated FY2023 revenue growth 7-10% and non-GAAP EPS $1.25-$1.50; GAAP loss per share $(0.28)-$(0.03).","Committed to Core Illumina non-GAAP operating margins of 25% in FY2024 and 27% in FY2025.","Shipped 67 NovaSeq X instruments in Q1 (exceeded plan); order book >200; plan >$100M annual cost savings."],"urls":{"canonical":"https://secwatch.observer/filing/0001110803-23-000028","json":"https://secwatch.observer/filing/0001110803-23-000028.json","markdown":"https://secwatch.observer/filing/0001110803-23-000028.md","text":"https://secwatch.observer/filing/0001110803-23-000028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1110803/000111080323000028/0001110803-23-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1110803/000111080323000028/ilmn-20230425.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T15:30:15.652750+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0eb7aa335f89bac60d42daa78a7d5ae18fababe6","claim":"ILLUMINA, INC. reported the first quarter ended April 2, 2023 results: revenue $1.09 billion, net income $3, EPS $0.02. Guidance reaffirmed.","evidence_excerpt":"Illumina Reports Financial Results for First Quarter of Fiscal Year 2023; Announces Commitment to Accelerate Margin Growth • Revenue of $1.09 billion for Q1 2023, up 1% from Q4 2022; down 11% from Q1 2022 (down 9% on a constant currency basis) • GAAP diluted EPS of $0.02 for Q1 2023, compared to GAAP diluted EPS of $0.55 for Q1 2022 • Non-GAAP diluted EPS of $0.08 for Q1 2023, compared to non-GAAP diluted EPS of $1.07 for Q1 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1110803/000111080323000028/0001110803-23-000028-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended April 2, 2023"},{"label":"Revenue","value":"$1.09 billion"},{"label":"Net income","value":"$3"},{"label":"EPS","value":"$0.02"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}